fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

Company Visit to Farmak JSC: Innovative Projects Investments – Not an Immediate Benefit, but Long-term Leadership

  • Date: 20/06/2018 (WED)
  • Language: Russian
  • Time: 10:00 - 13:00
  • Ticket:free of charge for EBA members
Place:

Farmak JSC, 63 Kyrylivska Str.

Google Apple Outlook Telegram Bot
  Company Visit to Farmak JSC: Innovative Projects Investments – Not an Immediate Benefit, but Long-term Leadership. Date: 20 June2018. Time: 10:00 13:00. Language: Russian. Ticket: free of charge for EBA members. Place: Farmak JSC, 63 Kyrylivska Str.. Registration is closed! To become the market leader in your sphere, it is important to choose the strategy of investing into modernization. EBA Management Development Centre team together with Farmak JSC invite you to participate in the Company Visit to Farmak JSC: Innovative Projects Investments - Not an Immediate Benefit, but Long-term Leadership. During the company visit you will understand why it is necessary to spend on innovations in order to be ahead of the revivals and which long-term investment projects allow to enter new markets. Speaker: Volodymyr Kostyuk, a.i.. Executive Director of PJSC Farmak. Partner: Farmak JSC Target audience: business owners. managers, senior managers, HR managers. Topics under discussion:  How much should the company invest into development to be in progress dynamically and hold leading positions? Why is it necessary to invest into projects that might be realised minimum in five years? How to increase business several times in 15 years, become the leader and the biggest exporter of pharmaceutical products in Ukraine? Registration is obligatory. To become a participant, please, click the “Register” button. Only the users of the EBA site can register at the event. Number of listeners is limited. Should you have any questions, please, write at [email protected] or call (044) 496-06-01.Speakers. Volodymyr Kostyuk. A.i.. Executive Director of PJSC Farmak. You can send a question to:. Contact person:. Anastasiia Mutas. E-mail [email protected]. Contact Phone. 044 496 06 01.

Registration is closed!

To become the market leader in your sphere, it is important to choose the strategy of investing into modernization.

EBA Management Development Centre team together with Farmak JSC invite you to participate in the Company Visit to Farmak JSC: Innovative Projects Investments – Not an Immediate Benefit, but Long-term Leadership. During the company visit you will understand why it is necessary to spend on innovations in order to be ahead of the revivals and which long-term investment projects allow to enter new markets.

Speaker: Volodymyr Kostyuk, a.i.. Executive Director of PJSC “Farmak”.

Partner: Farmak JSC

Target audience: business owners. managers, senior managers, HR managers.

Topics under discussion: 

  • How much should the company invest into development to be in progress dynamically and hold leading positions?
  • Why is it necessary to invest into projects that might be realised minimum in five years?
  • How to increase business several times in 15 years, become the leader and the biggest exporter of pharmaceutical products in Ukraine?

Registration is obligatory. To become a participant, please, click the “Register” button. Only the users of the EBA site can register at the event. Number of listeners is limited. Should you have any questions, please, write at [email protected] or call (044) 496-06-01.

Speakers

1 / 1
Volodymyr Kostyuk
A.i.. Executive Director of PJSC "Farmak"
Volodymyr Kostyuk

You can send a question to:

Contact person:

Anastasiia Mutas

Contact
044 496 06 01

Partners

Registration
First Name (ua)
Last Name (ua)
Job Title (ua)
First Name (en)
Last Name (en)
Job Title (en)
Contact Phone
Register If your company is already a member of the EBA and you have a personal cabinet / or want to create it, please follow the link.
Close - 0
Register
Close

Spelling error report

The following text will be sent to our editors: